Skip to main content

Nasdaq IPOs

Israel-focused SPAC ION Acquisition 2 prices $220 million IPO

5 years 7 months ago
ION Acquisition 2, the second blank check company formed by ION Asset Management targeting an Israeli tech business, raised $220 million by offering 22 million units at $10. Each unit consists of one share of common stock and one-eighth of a warrant, exercisable at $11.50. T
Renaissance Capital

Home healthcare equipment provider Apria prices IPO at $20 midpoint

5 years 7 months ago
Apria, which provides home healthcare equipment and services in the US, raised $150 million by offering 7.5 million shares (100% secondary) at $20, within the range of $19 to $21. At pricing, the company commands a fully diluted market value of $756 million. Backed by Blackstone
Renaissance Capital

French biotech Biophytis prices US IPO at $16.75, within the range

5 years 7 months ago
Biophytis, a French Phase 2 biotech developing therapies for COVID-related complications and age-related diseases, raised $20 million by offering 1.2 million ADSs at $16.75, within the range of $15 to $18. The company is currently listed on the Euronext Growth Paris (AL
Renaissance Capital

SPAC Lazard Growth Acquisition I prices $500 million IPO

5 years 7 months ago
Lazard Growth Acquisition I, a blank check company formed by Lazard targeting growth-oriented subsectors, raised $500 million by offering 50 million units at $10. Each unit consists of one share of common stock and one-fifth of a warrant, exercisable at $11.50. The company
Renaissance Capital
Checked
8 minutes 38 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed